List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 113 studies with search of: choroidal neovascularization | "Choroidal Neovascularization"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration
Conditions: Choroidal Neovascularization;   Macular Degeneration
Intervention: Drug: Corticosteroid
2 Active, not recruiting Ranibizumab in Hemorrhagic Choroidal Neovascularization Trial
Condition: Choroidal Neovascularization
Interventions: Drug: Ranibizumab;   Drug: Ranibizumab
3 Active, not recruiting Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks
Conditions: Angioid Streaks;   Choroidal Neovascularization
Intervention: Drug: Intravitreal Bevacizumab
4 Active, not recruiting Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization
Conditions: Macular Degeneration;   Choroidal Neovascularization
Interventions: Drug: Verteporfin for injection, Ranibizumab injection;   Drug: ranibizumab
5 Completed Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD)
Conditions: Choroidal Neovascularization;   Degenerative Myopia;   Pathological Myopia
Intervention: Drug: Bevacizumab
6 Active, not recruiting Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)
Conditions: Macular Degeneration;   Choroidal Neovascularization
Interventions: Drug: ranibizumab;   Drug: ranibizumab, verteporfin
7 Active, not recruiting Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
Conditions: Subfoveal Choroidal Neovascularization (CNV);   Secondary to Age-Related Macular Degeneration (AMD)
Intervention: Drug: ranibizumab
8 Withdrawn Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
Condition: Choroidal Neovascularization
Intervention: Drug: Imatinib Mesylate /Ranibizumab
9 Recruiting TTT Versus PDT for Treatment of Choroidal Neovascularization in Age-Related Macular Degeneration
Condition: Choroidal Neovascularization
Intervention: Procedure: Photodynamic therapy versus Transpupillary thermotherapy
10 Completed Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
Conditions: Choroidal Neovascularization;   Macular Degeneration
Intervention: Drug: ranibizumab
11 Completed SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
Conditions: Age-Related Macular Degeneration;   Choroidal Neovascularization
Intervention: Drug: ranibizumab
12 Recruiting Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration.
Condition: Choroidal Neovascularization
Intervention: Drug: ranibizumab
13 Completed Bevacizumab Intravitreal for Myopic Choroidal Neovascularization
Condition: Myopic Choroidal Neovascularization
Intervention: Drug: Injection
14 Recruiting Ranibizumab to Treat CNVs in Patients With PXE
Condition: Choroidal Neovascularization
Intervention: Drug: Intravitreal injection ranibizumab
15 Active, not recruiting Age-Related Macular Degeneration: Detection of Onset of New Choroidal Neovascularization (AMD DOC Study)
Conditions: Maculopathy, Age-Related;   Choroidal Neovascularization
Intervention:
16 Active, not recruiting Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD
Conditions: Macular Degeneration;   Choroidal Neovascularization
Intervention: Drug: TG100801
17 Completed A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
Conditions: Choroidal Neovascularization;   Age-Related Macular Degeneration
Intervention: Drug: rhuFab V2 (ranibizumab)
18 Completed Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)
Condition: Choroidal Neovascularization
Intervention: Drug: bevacizumab
19 Completed Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD
Conditions: Choroidal Neovascularization;   Macular Degeneration
Interventions: Drug: Verteporfin;   Drug: Bevacizumab
20 Completed Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
Condition: Subfoveal Choroidal Neovascularization(CNV) Secondary to Age-Related Macular Degeneration (AMD)
Intervention: Drug: Ranibizumab

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services